Section X               New Technology
Axis 6                  Device / Substance / Technology
Row         Add         
Term        Add         Amivantamab Monoclonal Antibody
Includes    Add         RYBREVANT(tm)
 
Row                     
Term                    Lisocabtagene Maraleucel Immunotherapy
Includes    Add         Breyanzi(R)
